Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions-Reference-Cited by-同舟云学术

Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions

Published:2016-02-20 Issue:1 Volume:11 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Unkel Steffen,Röver Christian,Stallard Nigel,Benda Norbert,Posch Martin,Zohar Sarah,Friede Tim

Funder

EU‘s 7th Framework Programme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-016-0402-6

Reference63 articles.

1. Orphan Medicinal Product Regulation. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Off J. 2000;L 18:15.

2. European Commission [Internet]. Brussels: Directorate-General for Health and Food Safety [cited 2015 Mar 20]. Available from: http://ec.europa.eu/health/rare_diseases/policy/ .

3. Editorial. Rare neurological diseases: a united approach is needed. Lancet Neurol. 2011;10(2):109.

4. Van Haren K, Waubant E. Therapeutic advances in pediatric multiple sclerosis. J Pediatr. 2013;163(3):631–7.

5. Orphanet [Internet]. Paris [updated 2015 July]. [cited 2015 Aug 7]. Available from: http://www.orpha.net .

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamically borrowing strength from another study through shrinkage estimation;Statistical Methods in Medical Research;2019-03-01

2. Semi‐parametric analysis of overdispersed count and metric data with varying follow‐up times: Asymptotic theory and small sample approximations;Biometrical Journal;2018-12-05

3. Recent advances in methodology for clinical trials in small populations: the InSPiRe project;Orphanet Journal of Rare Diseases;2018-10-25

4. Blinded continuous monitoring in clinical trials with recurrent event endpoints;Pharmaceutical Statistics;2018-10-21

5. Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases;Orphanet Journal of Rare Diseases;2018-06-28